Nasdaq

Bio-Techne To Acquire Namocell For Undisclosed Terms

(RTTNews) - Life sciences company Bio-Techne Corp. (TECH) announced Wednesday it has reached an agreement to acquire Namocell, Inc., a provider of fast and easy to use single cell sorting and ...
The Scientist

HepaTx, Namocell, and Takara Bio USA complete second phase of collaboration on single cell analysis for cell therapy to treat late-stage liver diseases

HepaTx Corporation, Namocell Inc., and Takara Bio USA, Inc. (TBUSA) announced successful completion of the second phase of their collaboration on single cell analysis of hepatocyte-like cells (iHeps) ...
Nasdaq

NAMOCELL HIGHLIGHTED IN NATURE PUBLICATION FOR EFFICIENT SINGLE CELL CLONING OF HUMAN PLURIPOTENT STEM CELLS

MINNEAPOLIS, Nov. 17, 2022 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced the publication of a single-cell cloning workflow study using the Namocell™ Single Cell Dispenser in ...
Medindia

Namocell, Takara Bio USA and HepaTx collaborate on single cell genomics analysis for cell therapy to treat late-stage liver diseases

Namocell Inc., a leading provider of single cell sorting and dispensing platforms has entered into a collaboration with Takara Bio and HepaTx to perform single cell isolation and analysis on HepaTx's ...